0001209191-15-019880.txt : 20150228 0001209191-15-019880.hdr.sgml : 20150227 20150227182845 ACCESSION NUMBER: 0001209191-15-019880 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150225 FILED AS OF DATE: 20150227 DATE AS OF CHANGE: 20150227 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVY BRIAN CENTRAL INDEX KEY: 0001277458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 15661312 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-25 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001277458 LEVY BRIAN C/O AERIE PHARMACEUTICALS, INC., 2030 MAIN STREET, SUITE 1500 IRVINE CA 92614 0 1 0 0 Chief Medical Officer Common Stock 2015-02-25 4 A 0 10313 0.00 A 16313 D Stock Option (right to buy) 28.03 2015-02-25 4 A 0 61875 0.00 A 2025-02-25 Common Stock 61875 61875 D These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in four equal annual installments on the anniversary of February 25, 2015. This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, ratably on each of the 48 monthly anniversaries of February 25, 2015. /s/ Richard J. Rubino, Attorney-in-Fact for Brian Levy 2015-02-27